BioNexus Gene Lab Corp. Stock-Based Compensation
BioNexus Gene Lab Corp. (BGLC) reported Stock-Based Compensation of $794.77 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-04-14
- BioNexus Gene Lab Corp. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $794.77K.
- BioNexus Gene Lab Corp. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $0.00.
- BioNexus Gene Lab Corp. share-based payment arrangement, noncash expense for fiscal 2025 was $794.77K, a 463.67% increase from fiscal 2024.
- BioNexus Gene Lab Corp. share-based payment arrangement, noncash expense for fiscal 2024 was $141.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $794.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $794.77K 10-K · filed 2026-04-14 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $141.00K 10-K · filed 2026-04-14 | |
| 2024-09-30 | $141.00K 10-Q · filed 2025-11-14 | ||
| 2023-09-30 | $601.74K 10-Q · filed 2024-11-15 | ||
| 2022-09-30 | $0.00 10-Q/A · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |